120,000 Shares in iShares Biotechnology ETF $IBB Acquired by Henshaw Capital LLC

Henshaw Capital LLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the first quarter, HoldingsChannel reports. The institutional investor bought 120,000 shares of the financial services provider’s stock, valued at approximately $20,262,000.

Other large investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC boosted its stake in shares of iShares Biotechnology ETF by 46,806.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after acquiring an additional 46,806 shares during the last quarter. McElhenny Sheffield Capital Management LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $25,400,000. Assetmark Inc. grew its holdings in iShares Biotechnology ETF by 150,979.6% in the fourth quarter. Assetmark Inc. now owns 74,029 shares of the financial services provider’s stock valued at $12,494,000 after purchasing an additional 73,980 shares during the period. WorthPointe LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $1,424,000. Finally, HBW Advisory Services LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth about $1,027,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $186.41 on Friday. iShares Biotechnology ETF has a one year low of $130.25 and a one year high of $199.05. The company’s 50 day moving average price is $181.72 and its 200 day moving average price is $174.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a $0.0238 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.